|Name||Tissue||Type of pathologies|
|Acute and chronic cervical and lumbar pain||Muscle||Idiopathic cervical and low back pain|
|Acute and chronic soft tissue wounds||Skin||Wounds|
|Calcifying tendinitis of the shoulder||Tendons||Tendinopathy|
|Greater trochanteric pain syndrome||Tendons||Tendinopathy|
|Insertional Achilles tendinopathy||Tendons||Tendinopathy|
|Medial tibial stress syndrome||Tendons||Tendinopathy|
|Mid-body Achilles tendinopathy||Tendons||Tendinopathy|
|Osgood-Schlatter disease||Bone||Disturbance of musculoskeletal development|
|Patella tip syndrome||Tendons||Tendinopathy|
|Primary and secondary lymphedema||Skin||Lymphedema|
|Proliferative connective tissue disorders||Connective tissue||Fibrosis|
|Subacromial pain syndrome||Tendons||Tendinopathy|
|Trigger points||Muscle||Myofascial pain syndrome|
Plantar fasciopathy (PF) is an acute or chronic, painful disorder of the plantar fascia that spans between the medial calcaneal tubercle and the proximal phalanges of the toes.
It is the most common cause of plantar heel pain and accounts for approximately 11-15% of foot symptoms presenting to physicians. The main clinical symptom is heel pain, particularly in the morning or after a period of rest. Often patients report improvement of pain after walking. Pain is usually located at the origin of the plantar fascia, i.e., at the medial calcaneal tubercle. Passive dorsiflexion of the toes may aggravate the pain in some patients, particularly in those with chronic PF. Patients suffering from chronic PF may also present with heel pad swelling.
Diagnosis is based on the clinical features of the disease. Diagnostic imaging should be considered to rule out other causes of plantar heel pain or to establish the diagnosis of PF when in doubt. Histologic examination of biopsy specimens from patients undergoing plantar fascia release surgery for chronic symptoms has shown that chronic PF is associated with degenerative changes in the fascia. Accordingly, the disease is better characterized as “fasciopathy” than “fasciitis”, resembling the situation in overuse tendon problems.
In the United States, more than two million individuals are treated for PF on an annual basis. Up to 10% of the population will experience plantar heel pain during the course of a lifetime. Both athletes and the elderly commonly present to physicians with PF.
The treatment of PF should start with conservative treatment modalities including rest, physiotherapy, stretching, exercises, shoe inserts/orthotics, night splints, non-steroidal anti-inflammatory drugs, and local corticosteroid injections. Patients not responding to conservative treatment for six months (between 10% and 20% of all patients) shall then be subjected to radial shock wave therapy (RSWT). Surgery should be considered for recalcitrant cases of PF.
Akinoglu et al., Pain Med 2017: Epub ahead of print on May 29
Comparison of the Acute Effect of Radial Shock Wave Therapy and Ultrasound Therapy in the Treatment of Plantar Fasciitis: A Randomized Controlled Study.READ ABSTRACT
Ibrahim et al., J Orthop Res 2017;35:1532-1538.
Long-term results of radial extracorporeal shock wave treatment for chronic plantar fasciopathy: A prospective, randomized, placebo-controlled trial with two years follow-up.READ ABSTRACT
Eslamian et al., Pain Med 2016;17:1722-1731.
Extra Corporeal Shock Wave Therapy Versus Local Corticosteroid Injection in the Treatment of Chronic Plantar Fasciitis, a Single Blinded Randomized Clinical Trial.READ ABSTRACT
Konjen et al., J Med Assoc Thai 2015;98:S49-S56.
A comparison of the effectiveness of radial extracorporeal shock wave therapy and ultrasound therapy in the treatment of chronic plantar fasciitis: a randomized controlled trialREAD ABSTRACT
Rompe et al., Int J Surg 2015;24:135-142.
Radial shock wave treatment alone is less efficient than radial shock wave treatment combined with tissue-specific plantar fascia-stretching in patients with chronic plantar heel painREAD ABSTRACT
Grecco et al., Clinics 2013;68:1089-1095.
One-year treatment follow-up of plantar fasciitis: radial shockwaves vs. conventional physiotherapyREAD ABSTRACT
Ibrahim et al., Foot Ankle Int 2010;31:391-397.
Chronic plantar fasciitis treated with two sessions of radial extracorporeal shock wave therapyREAD ABSTRACT
Rompe et al., J Bone Joint Surg Am 2010;92:2514-2522.*
Plantar fascia-specific stretching versus radial shock-wave therapy as initial treatment of plantar fasciopathyREAD ABSTRACT
Shaheen, Indian J Physiother Occupat Therap 2010;4:8-12.
Low-energy radial extracorporeal shock wave treatment for chronic plantar fasciitis: a randomized control trialREAD ABSTRACT
Greve et al., Clinics 2009;64:97-103.
Comparison of radial shockwaves and conventional physiotherapy for treating plantar fasciitisREAD ABSTRACT
Gerdesmeyer et al., Am J Sports Med 2008;36:2100-2109.
Radial Extracorporeal Shock Wave Therapy Is Safe and Effective in the Treatment of Chronic Recalcitrant Plantar Fasciitis : Results of a Confirmatory Randomized Placebo-Controlled Multicenter StudyREAD ABSTRACT
Marks et al., Acta Orthop Belg 2008;74:98-101.**
Extracorporeal shock-wave therapy (ESWT) with a new-generation pneumatic device in the treatment of heel pain. A double blind randomised controlled trial.READ ABSTRACT
Chow and Cheing, Clin Rehabil 2007;21:131-141.
Comparison of different energy densities of extracorporeal shock wave therapy (ESWT) for the
management of chronic heel pain
Mehra et al., Surgeon 2003;1:290-292.
The use of a mobile lithotripter in the treatment of tennis elbow and plantar fasciitis.READ ABSTRACT
|STANDARD TREATMENT||MYOFASCIAL THERAPY|
|Number of treatment sessions||3 to 5||3 to 5|
|Interval between two sessions||1 week||1 week|
|Air pressure Evo Blue®||2 to 4 bar||3 to 4 bar|
|Air pressure Power+||1.5 to 3 bar||2 to 4 bar|
|Impulses||2000 on the painful spot||2000|
|Frequency||8Hz to 12Hz||12Hz to 20Hz|
|Skin pressure||Moderate to high||Moderate to Heavy|
I agree that E.M.S. Electro Medical Systems S.A., with registered office at Che. de la Vuarpillière 31, CH 1260-Nyon, collects the personal information that I have filled in above. These information will be used to provide me with the services requested above.
I would like to receive quarterly newsletters of E.M.S. Electro Medical Systems S.A. by email with updates about its medical products, and the SDCA. I understand that my data will be used in order to receive marketing information and will not be forwarded to third parties. I can revoke my consent at any time by sending an email to firstname.lastname@example.org with effect for the future, or by clicking on the unsubscribe link on each email.